'Outstanding Data': Mosunetuzumab in R/R Follicular Lymphoma

The investigational monoclonal antibody showed impressive activity in patients with follicular lymphoma that had relapsed or was refractory to a median of 3 prior lines of therapy.
Medscape Medical News

source https://www.medscape.com/viewarticle/964647?src=rss

Comments

Popular posts from this blog

RA and RA-ILD Linked to Higher Lung Cancer Risk

Heart Failure Care Outside of ICU Can Lower Cost